| 101 |
12499281 | Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. | 2002 Dec 15 |
2 |
| 102 |
11279186 | Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53. | 2001 May 11 |
1 |
| 103 |
11595686 | Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. | 2001 Oct |
2 |
| 104 |
11720475 | Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2. | 2001 Nov 2 |
1 |
| 105 |
10637254 | p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck. | 2000 Jan |
1 |
| 106 |
10692490 | Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line. | 2000 Mar |
2 |
| 107 |
10955812 | Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. | 2000 Aug |
1 |
| 108 |
11099323 | p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma. | 2000 Dec 1 |
2 |
| 109 |
10100719 | Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV). | 1999 Mar |
4 |
| 110 |
10471039 | A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. | 1999 Aug |
2 |
| 111 |
9464331 | [Survival in patients with clear cell carcinoma of the ovary]. | 1998 Jan |
2 |
| 112 |
9714063 | Characterisation of the p53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines. | 1998 Sep 11 |
1 |
| 113 |
9797696 | Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer. | 1998 May |
1 |
| 114 |
9891541 | p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy. | 1998 Nov-Dec |
1 |
| 115 |
9042215 | Preoperative serum antibodies against the p53 protein in patients with ovarian and endometrial cancer. | 1996 Nov-Dec |
2 |
| 116 |
21544361 | Platinum-sensitive and platinum-resistant ovarian cancer tissues show differences in the relationships between mRNA levels of p53, ERCC1 and XPA. | 1996 Feb |
7 |